OBJECTIVE There have been no studies undertaken on the effect of the multidisciplinary
head and neck tumor board on treatment planning. The objective of this study was to …

Background: Tumor heterogeneity and evolutionary complexity may underlie treatment
failure in spite of the development of many targeted agents. We suggest a novel strategy …

Recent evidence suggests that head-and-neck radiotherapy (HNRT) increases active forms
of matrix metalloproteinase-20 (MMP-20) in human tooth crowns, degrading the dentin …

AIMS: A significant proportion of patients with head and neck squamous cell carcinoma are
unsuitable for radical treatment due to factors including tumour stage, performance status …

Background/Aim: Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most
common type of cancer worldwide; 600,000 new cases are diagnosed every year. Infected …

AIMS: Several randomised trials have tested adjuvant regimens using concomitant high-
dose cisplatin and radiotherapy to improve outcome in high-risk locally advanced squamous …

Aim: To evaluate treatment-related factors such as overall treatment time (OTT) and radiation
treatment time (RTT) in head-and-neck cancer. Patients and Methods: A total of 216 patients …

AIMS: To model the therapeutic gain from the addition of synchronous chemotherapy to
radiotherapy in locally advanced head and neck cancer. MATERIALS AND METHODS …

NYNKCGWJPNZJMI-UHFFFAOYSA-N 4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-
methoxybenzamide; 2-hydroxybutanedioic acid Chemical compound [O-] C (= O) C (O) CC …

NYNKCGWJPNZJMI-UHFFFAOYSA-N 4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-
methoxybenzamide; 2-hydroxybutanedioic acid Chemical compound [O-] C (= O) C (O) CC …